Home/Learn

Peptide Learn Library

Researched explainers on peptide compounds, mechanisms, and applications. Every article is grounded in peer-reviewed sources and reviewed by our editorial team before publishing.

Apr 18, 2026

MOTS-c: The Mitochondrial Peptide for Metabolism and Muscle Health

MOTS-c is a mitochondrial-derived peptide that may enhance fat metabolism, preserve muscle mass, and improve energy production. Learn about mechanisms and re…

Read article

Apr 18, 2026

CJC-1295 and Ipamorelin: Benefits, Risks, and Safety Considerations

Comprehensive guide to CJC-1295 and ipamorelin peptides: clinical research, potential benefits for sleep and metabolism, safety profile, and practical use.

Read article

Apr 17, 2026

KPV Peptide for Gut Healing and Inflammation: Research and Applications

Explore KPV peptide's anti-inflammatory mechanisms for gut healing, its role in colitis models, and how it complements BPC-157, TB-500, and GHK-Cu in peptide…

Read article

Apr 17, 2026

BPC-157 and the Wolverine Stack: What 100+ Peptide Users Report

Real-world experiences with BPC-157, TB-500, and other research peptides from 100+ users. Learn about recovery, side effects, and what the science says.

Read article

Apr 16, 2026

AOD-9604 for Fat Loss: Mechanisms, Research, and Practical Insights

Comprehensive guide to AOD-9604 peptide for fat loss. Learn about mechanisms, clinical research, dosing protocols, and how it compares to other metabolic pep…

Read article

Apr 16, 2026

GHK-Cu 8-Week Results: Skin, Hair, and Recovery Effects Explained

Explore GHK-Cu peptide's effects on skin aging, hair quality, and recovery. Learn about dosing, mechanisms, and what 8 weeks of use may reveal.

Read article

Apr 15, 2026

Retatrutide: The Triple-Agonist Peptide Revolutionizing Fat Loss

Retatrutide combines GLP-1, GIP, and glucagon receptor agonism for unprecedented fat loss. Learn how this triple-agonist peptide works, clinical results, and…

Read article

Apr 15, 2026

Peptides to Avoid in 2026: A Safety-First Guide to Peptide Therapy

Learn which peptides carry the highest risks in 2026, including oral BPC-157, CJC-1295 with DAC, and MK-677. Evidence-based safety guidance for peptide therapy.

Read article

Apr 14, 2026

BPC-157 Peptide Protocols: Evidence-Based Approaches to Tissue Repair

Explore BPC-157 mechanisms, dosing protocols, and combination approaches with TB-500 for tissue repair. Evidence-based analysis of angiogenesis and healing.

Read article